naltrexone has been researched along with 4-aminopyridine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bencsik, K; Mihály, A; Solymosi, T | 1 |
| Brotchie, JM; Hill, MP | 1 |
| McGinty, JF; Rawls, SM; Terrian, DM | 1 |
| Alves, DP; Amarante, LH; Duarte, ID | 1 |
| McDermott, CM; Schrader, LA | 1 |
5 other study(ies) available for naltrexone and 4-aminopyridine
| Article | Year |
|---|---|
Naltrexone potentiates 4-aminopyridine seizures in the rat.
Topics: 4-Aminopyridine; Animals; Convulsants; Dose-Response Relationship, Drug; Female; Naltrexone; Rats; Reaction Time; Receptors, Opioid; Receptors, Opioid, mu; Seizures | 1990 |
Control of glutamate release by calcium channels and kappa-opioid receptors in rodent and primate striatum.
Topics: 4-Aminopyridine; Animals; Benzofurans; Calcium Channel Blockers; Calcium Channels; Callithrix; Glutamic Acid; In Vitro Techniques; Male; Naltrexone; Narcotic Antagonists; Neostriatum; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Spider Venoms; Synaptosomes; Tetrodotoxin | 1999 |
Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes.
Topics: 4-Aminopyridine; Animals; Calcium; Chelating Agents; Dicarboxylic Acids; Egtazic Acid; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Glutamic Acid; In Vitro Techniques; Male; Muscarinic Agonists; Muscarinic Antagonists; Naltrexone; Narcotic Antagonists; Neostriatum; Nerve Endings; Neurotransmitter Uptake Inhibitors; Potassium Channel Blockers; Potassium Channels; Pyrrolidines; Rats; Rats, Wistar; Receptors, Muscarinic; Receptors, Opioid, kappa; Receptors, Presynaptic; Synaptosomes | 1999 |
Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine.
Topics: 4-Aminopyridine; Analgesics; Animals; ATP-Binding Cassette Transporters; Benzomorphans; Charybdotoxin; Cyclic GMP; Dequalinium; Glyburide; Hyperalgesia; KATP Channels; Male; Naltrexone; Nitric Oxide; Peripheral Nervous System; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar; Receptors, Opioid, kappa; Signal Transduction; Tetraethylammonium; Tolbutamide | 2004 |
Activation of κ opioid receptors increases intrinsic excitability of dentate gyrus granule cells.
Topics: 4-Aminopyridine; Action Potentials; Animals; Benzeneacetamides; Dentate Gyrus; Dynorphins; GTP-Binding Proteins; Guanosine Diphosphate; Male; Mice; Mice, 129 Strain; Naltrexone; Neurons; Patch-Clamp Techniques; Potassium Channels; Pyrrolidines; Receptors, Opioid, kappa; Thionucleotides | 2011 |